Zenlabs Ethica Ltd

AI
Zenlabs Ethica Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Zenlabs Ethica Ltd

₹ 27.0 2.32%
23 Oct - close price
zenlabsindia.com ; www.zenlabsethica.com BSE: 530697
About

Incorporated in 1993, Zenlabs Ethica Ltd deals in marketing and distribution of pharmaceutical products.[1]

Key Points

Business Overview:[1][2]
a) ZEL is a part of the Preet Remedies Group. It is a WHO–GMP certified contract manufacturing pharmaceutical firm which operates across manufacturing and distributing diversified pharmaceutical formulations under multiple divisions (Zenlabs, Coles Pharma, Mega Star), servicing both domestic and international markets including Southeast Asia.
b) The company does third party manufacturing for Preet Remedies Group which has 5 production units namely Preet Remedies Pvt. Ltd., Oasis Pharma & Phytomolecules Pvt. Ltd., Quixotic Healthcare Unit I & II, and Alpha Products. At any of these facilities, the minimum
order quantity offered is 2000 boxes
of drugs.
c) The company is also into private label manufacturing of different pharmaceutical products.

Website BSE
  • Market Cap ₹ 17.5 Cr.
  • Current Price ₹ 27.0
  • High / Low ₹ 40.0 / 16.5
  • Stock P/E
  • Book Value ₹ 13.1
  • Dividend Yield 0.00 %
  • ROCE 5.07 %
  • ROE 0.21 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -3.70% over past five years.
  • Company has a low return on equity of 2.39% over last 3 years.
  • Company might be capitalizing the interest cost
  • Promoter holding has decreased over last 3 years: -6.16%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Services Services Commercial Services & Supplies Diversified Commercial Services

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
13.57 14.06 15.60 15.33 12.36 13.35 12.72 12.99 11.48 12.43 12.43 10.58 14.18
13.04 13.62 14.91 14.57 11.74 12.73 12.04 12.33 10.93 11.98 11.91 10.31 14.47
Operating Profit 0.53 0.44 0.69 0.76 0.62 0.62 0.68 0.66 0.55 0.45 0.52 0.27 -0.29
OPM % 3.91% 3.13% 4.42% 4.96% 5.02% 4.64% 5.35% 5.08% 4.79% 3.62% 4.18% 2.55% -2.05%
0.05 0.22 0.00 0.02 0.00 0.00 0.00 0.04 0.00 0.06 -2.08 0.12 0.00
Interest 0.16 0.21 0.22 0.25 0.23 0.23 0.24 0.23 0.21 0.19 0.23 0.18 0.16
Depreciation 0.32 0.32 0.32 0.33 0.32 0.31 0.32 0.31 0.29 0.24 0.23 0.14 0.11
Profit before tax 0.10 0.13 0.15 0.20 0.07 0.08 0.12 0.16 0.05 0.08 -2.02 0.07 -0.56
Tax % 30.00% 30.77% 26.67% 25.00% 42.86% 25.00% 33.33% 43.75% 20.00% 50.00% 0.00% 114.29% 3.57%
0.07 0.09 0.11 0.15 0.04 0.05 0.09 0.09 0.03 0.04 -2.01 0.00 -0.57
EPS in Rs 0.11 0.14 0.17 0.23 0.06 0.08 0.14 0.14 0.05 0.06 -3.09 0.00 -0.88
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
0.00 15.09 78.73 69.85 65.37 58.50 56.64 69.09 66.89 58.56 51.42 46.92 49.62
0.05 14.89 77.28 68.00 63.28 59.20 54.89 66.70 63.98 56.15 48.84 45.13 48.67
Operating Profit -0.05 0.20 1.45 1.85 2.09 -0.70 1.75 2.39 2.91 2.41 2.58 1.79 0.95
OPM % 1.33% 1.84% 2.65% 3.20% -1.20% 3.09% 3.46% 4.35% 4.12% 5.02% 3.82% 1.91%
0.00 -0.03 0.08 0.10 0.10 0.05 0.11 0.09 -0.45 0.30 0.04 -1.90 -1.90
Interest 0.00 0.02 0.10 0.09 0.07 0.23 0.29 0.37 0.53 0.83 0.93 0.81 0.76
Depreciation 0.01 0.06 0.20 0.20 0.23 0.29 0.71 0.89 1.25 1.29 1.26 0.89 0.72
Profit before tax -0.06 0.09 1.23 1.66 1.89 -1.17 0.86 1.22 0.68 0.59 0.43 -1.81 -2.43
Tax % 16.67% -88.89% 21.95% 29.52% 32.80% -36.75% 10.47% 36.07% 26.47% 27.12% 37.21% 6.63%
-0.07 0.17 0.95 1.16 1.26 -0.73 0.77 0.78 0.49 0.42 0.27 -1.94 -2.54
EPS in Rs -0.18 0.26 1.46 1.78 1.94 -1.12 1.18 1.20 0.75 0.65 0.41 -2.98 -3.91
Dividend Payout % 0.00% 0.00% 16.32% 0.00% 0.00% 0.00% 0.00% 0.00% 33.21% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 12%
5 Years: -4%
3 Years: -11%
TTM: -2%
Compounded Profit Growth
10 Years: -23%
5 Years: -52%
3 Years: -72%
TTM: -277%
Stock Price CAGR
10 Years: 4%
5 Years: -4%
3 Years: -9%
1 Year: -5%
Return on Equity
10 Years: 7%
5 Years: 5%
3 Years: 2%
Last Year: 0%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3.62 6.20 6.20 6.20 6.51 6.51 6.51 6.51 6.51 6.51 6.51 6.51
Reserves -1.65 -1.41 -0.41 0.81 1.77 0.90 2.05 2.82 3.19 3.61 3.92 2.00
0.00 1.09 0.96 0.85 0.60 0.73 2.60 3.90 5.85 14.86 12.71 10.98
1.77 24.49 26.62 21.96 26.01 25.85 21.04 24.66 27.95 15.28 17.48 17.71
Total Liabilities 3.74 30.37 33.37 29.82 34.89 33.99 32.20 37.89 43.50 40.26 40.62 37.20
0.06 1.68 1.50 1.33 1.36 1.12 3.51 3.53 5.03 3.70 2.29 1.87
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 1.25 0.95 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.00
3.68 27.44 30.92 27.79 32.83 32.17 27.99 33.66 37.77 35.86 37.63 35.33
Total Assets 3.74 30.37 33.37 29.82 34.89 33.99 32.20 37.89 43.50 40.26 40.62 37.20

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.02 0.92 -1.06 0.36 0.80 0.45 -8.41 -0.38 1.52 -9.06 3.83 4.06
0.00 -1.69 -0.02 -0.03 -0.22 0.01 0.15 0.00 -1.47 0.11 0.14 0.00
0.00 3.23 -0.27 -0.23 -0.14 -0.03 -0.52 0.31 0.06 8.24 -3.08 -2.95
Net Cash Flow 0.02 2.47 -1.35 0.09 0.44 0.43 -8.78 -0.07 0.11 -0.71 0.88 1.11
Free Cash Flow 0.02 -0.77 -1.08 0.33 0.49 0.40 -8.35 -0.41 -0.03 -9.08 3.96 4.06
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -40% 460% -73% 19% 38% -64% -475% -11% 62% -371% 157% 234%

Ratios

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 398.14 107.65 126.40 139.37 138.76 121.67 109.57 118.41 129.21 138.70 122.13
Inventory Days 249.62 34.42 11.12 31.23 33.95 40.46 56.05 77.85 100.05 128.43 161.14
Days Payable 665.46 136.41 125.88 161.27 165.31 150.28 141.30 174.04 101.21 140.00 165.22
Cash Conversion Cycle -17.70 5.66 11.64 9.33 7.40 11.85 24.32 22.21 128.04 127.13 118.05
Working Capital Days 4.84 13.40 21.95 28.42 24.02 27.97 35.34 34.98 47.31 52.74 39.44
ROCE % -2.99% 9.94% 21.06% 23.96% 24.13% -11.05% 12.02% 13.04% 12.44% 7.01% 5.69% 5.07%

Insights

In beta
Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of permanent employees
employees

Log in to view insights

Please log in to see hidden values.

Login
Number of therapeutic categories
categories
Export revenue as % of total revenue
%
Number of products in portfolio
products

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
59.12% 52.97% 52.97% 52.96% 52.96% 52.96% 52.96% 52.96% 52.96% 52.96% 52.96% 52.96%
40.88% 47.01% 47.02% 47.04% 47.04% 47.04% 47.03% 47.04% 47.04% 47.05% 47.04% 47.04%
No. of Shareholders 2,1992,4822,4622,6352,6302,6632,6482,7122,7742,7562,7172,697

Documents

Announcements

Annual reports